RBC Capital analyst Nik Modi maintained a Hold rating on Kenvue, Inc. (KVUE – Research Report) today and set a price target of $24.00. The ...
Get a deeper insight into the potential performance of Kenvue (KVUE) for the quarter ended December 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for ...
Barclays analyst Lauren Lieberman maintained a Hold rating on Kenvue, Inc. (KVUE – Research Report) today and set a price target of $21.00. The ...
Kenvue (KVUE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Kenvue (NYSE:KVUE – Get Free Report) is expected to be issuing its quarterly earnings data before the market opens on ...
Kenvue Inc . (NYSE:KVUE), the consumer health company spun off from Johnson & Johnson in 2023, finds itself at a critical juncture as it navigates its first full year as an independent entity. The ...
Dakota Wealth Management raised its position in Kenvue Inc. (NYSE:KVUE – Free Report) by 25.6% during the 4th quarter, ...
On Monday, Kenvue Inc (KVUE) stock saw a modest uptick, ending the day at $21.44 which represents a slight increase of $0.66 or 3.18% from the prior close of $20.78. The stock opened at $ and touched ...